University of Notre
Dame1 researchers Shahriar Mobashery and Mayland Chang and their collaborators in Spain have published research results this week that show how methicillin-
resistant2 Staphylococcus aureus (MRSA) regulates the critical crosslinking of its cell wall in the face of beta-
lactam(内酰胺) antibiotics4. The work, published in the
Proceedings5 of the National Academy of Sciences, reveals the mechanistic basis for how the MRSA
bacterium6 became such a difficult pathogen over the previous 50 years, in which time it spread rapidly across the world. Modern strains of MRSA have become broadly resistant to antibiotics, including beta-lactam antibiotics, such as
penicillins(青霉素). In their report, the researchers disclose the discovery of an
allosteric(变构的) domain8 in the X-ray structure of the
penicillin7 binding10 protein 2a of MRSA, the
enzyme11 that carries out the crosslinking reaction. (An allosteric site is a place on the protein where its activity is regulated by the binding of another
molecule12.)
Mobashery, Chang and Juan Hermoso at CSIC, the Spanish Research Council, document that an allosteric trigger by a fragment of the cell wall at a distance of 60 Ångstroms (6 nanometers)
activates13 a set of conformational changes that
culminates14 in the opening of the active site from a closed conformation, enabling catalysis for the
physiological15 role of the enzyme.
They also document that the new beta-lactam
antibiotic3 ceftaroline, recently approved by the Food and Drug Administration, is able to
bind9 to the allosteric domain and trigger the same allosteric opening of the active site. This
subversion16 of the allosteric control allows another molecule of ceftaroline to access the active site, which
inhibits17 the function of the enzyme, leading to cell death by MRSA. This
mechanism18 of action for the antibiotic is
unprecedented19 and offers important insights for design of future drugs to combat MRSA.
MRSA has been a difficult hospital pathogen to control and has emerged in the broader community in the past several years, especially in such places as prisons,
locker20 rooms and nurseries. In the United States alone, the disease infects about 100,000 people and claims the lives of nearly 20,000 people
annually21.